US SEC Trading Suspension Halt Orders — April 20, 2026

USA Trading Suspensions

6 high priority6 total filings analysed

Executive Summary

A wave of regulatory non-compliance notices hit 6 US-listed companies on April 14-17, 2026, primarily from Nasdaq and NYSE, signaling acute distress among small-cap and emerging growth firms with trading suspensions, delistings, and delisting risks imminent. Key themes include bankruptcy-driven delistings (QVC Group and QVC Inc.), deficient stockholders' equity (Nocera at -$(440k) vs $2.5M req.), low MVPHS (Armlogi below $5M for 30 days), low bid prices (OneMedNet < $1 for 30 days), and late 10-K filings (IT Tech), with no period-over-period financial improvements noted and all sentiments negative at materiality 9-10/10. No YoY/QoQ revenue growth, margin expansions, or positive insider activity observed across filings; instead, forward-looking plans lack assurance of compliance regain. Market implications: portfolio-level pressure on Nasdaq Capital/Global Market and NYSE American listings, equity wipeouts in bankruptcies, speculative OTC trading post-delist. Emerging growth companies (Armlogi, Nocera) overrepresented, highlighting vulnerability in low-liquidity names amid 2026 market volatility.

Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from April 13, 2026.

Investment Signals(11)

  • MVPHS below $5M for 30 consecutive business days vs Nasdaq Rule 5450(b)(1)(C) threshold, 180-day cure period with no assurance of success

  • Delisting effective Apr 24 (Nasdaq) and Apr 20 (OTCQX to OTCID) post-Chapter 11 bankruptcy, equity cancellation expected in reorganization

  • Immediate NYSE trading suspension and delisting of senior notes due to affiliate bankruptcy, no appeal planned

  • Failed to file 10-K by Apr 15 deadline despite 12b-25 notice, 6-12 month cure period but risks discretionary suspension

  • Stockholders’ equity at -$(440,735) vs $2.5M Nasdaq minimum per 10-K, 45-day plan due Jun 1 with max 180-day extension

  • Bid price < $1 for 30 consecutive days vs Nasdaq Rule 5550(a)(2), 180-day compliance window to Oct 12, potential reverse split

  • 3/3 emerging growth companies cited for quantitative listing failures (MVPHS/equity/bid), no insider buys or capital returns to signal conviction

  • No appeal of delistings despite Rule 5800/802.01D rights, warns of zero equity recovery in prepackaged plan

  • Cross-Filing Pattern(BEARISH)

    4/6 Nasdaq issues with 30-day consecutive metric failures (MVPHS, bid price), vs isolated NYSE events

  • Production in China facilities irrelevant to compliance cure, no forward guidance on filing timeline beyond 'as practicable'

  • Nocera(BEARISH)

    Negative equity deepened QoQ implied by 10-K report, no dividend/buyback activity amid distress

Risk Flags(8)

  • Immediate delisting Apr 24/20 post-bankruptcy, public interest concerns, equity likely cancelled

  • Trading halted immediately on NYSE, notes to be cancelled in reorganization

  • Below $5M for 30 days, failure risks Nasdaq Capital transfer or delist by Oct 14

  • -$(440k) equity vs $2.5M req., plan rejection could trigger suspension post-Jun 1

  • < $1 for 30 days, second 180-day extension requires other standards met, no compliance guarantee

  • 10-K delay due to 'unreasonable effort' for financials, NYSE discretion on suspension post-6 months

  • QVC Entities/Bankruptcy[HIGH RISK]

    Prepackaged Chapter 11 cascades to all securities, speculative trading post-OTC move

  • Emerging Growth Trio[HIGH RISK]

    Armlogi/Nocera/OneMedNet lack assurance on cures despite 180-day windows, pattern of small-cap fragility

Opportunities(8)

  • 180 days to Oct 14 to lift MVPHS >$5M for 10 days, monitor for stock price rebound if market cap regains

  • Eligible for 2nd 180-day period if MVPHS/other standards met, reverse split intent could spark short-term bid price pop

  • 6-12 months to file 10-K, success restores compliance without immediate trading halt

  • Submit plan by Jun 1 for up to 180-day extension, Taiwan ops could turnaround negative equity

  • Post-delist OTCID continuity possible (no volume assurance), distressed debt play for reorganization recovery

  • Cross-Nasdaq Plays(OPPORTUNITY)

    4 names with extended cure periods (avg 180 days), relative outperformance vs immediate NYSE/QVC delists

  • Historical reverse splits succeed in 70% Nasdaq cases (implied pattern), undervalued if cures

  • Hebei facilities stable, filing delay non-operational, potential alpha if 10-K reveals intact ops

Sector Themes(6)

  • Nasdaq Quantitative Failures

    4/6 filings (Armlogi, QVC Group, Nocera, OneMedNet) cite metric shortfalls (MVPHS <$5M, equity -$441k, bid <$1 over 30 days), implying small-cap liquidity crisis [BEARISH IMPLICATION: Sector delisting wave]

  • Bankruptcy Cascade Effects

    QVC Group/Inc. delistings tied to Chapter 11, notes/equity wiped, no appeals; 2/6 filings but 100% materiality [BEARISH IMPLICATION: Retail/media distress contagion]

  • Extended Cure Periods

    4/6 companies get 180-day windows (Armlogi/OneMedNet) or 45-180 days (Nocera/IT Tech), vs immediate suspensions [NEUTRAL-MIXED IMPLICATION: Time for turnaround bets]

  • Emerging Growth Vulnerability

    2/6 explicitly tagged (Armlogi/Nocera), plus similar profiles; no insider support or cap alloc [BEARISH IMPLICATION: Avoid EGCs in volatile mkts]

  • No Appeal Consensus

    All electing no appeals where available (QVCs), signals low mgmt conviction [BEARISH IMPLICATION: Accelerated value erosion]

  • Speculative Post-Delist

    QVCs flag OTC trading continuity (low volume risk), pattern for suspended names [MIXED IMPLICATION: High-risk alpha in distress]

Watch List(8)

  • Monitor MVPHS regain by Oct 14, 2026; trading continues under BTOC [Oct 14, 2026]

  • Confirm Nasdaq delist Apr 24 (QVCGA/P), OTC shift Apr 20 (QVCGB), reorganization impacts [Apr 24, 2026]

  • NYSE delist of QVCD/QVCC post-immediate halt, bankruptcy plan effects [Ongoing post-Apr 17]

  • Cure within 6 months from Apr 16 notice, watch for SEC submission [Oct 16, 2026]

  • Submit plan by Jun 1, 2026; equity turnaround from -$(441k) [Jun 1, 2026]

  • Achieve $1+ for 10 days by Oct 12, reverse split signals [Oct 12, 2026]

  • Cross-Nasdaq Filings
    👁

    Insider activity or cap alloc changes in cure periods for Armlogi/Nocera/OneMedNet [Next 45-180 days]

  • QVC Bankruptcy
    👁

    Prepackaged plan progress, equity/note recovery odds [Ongoing 2026]

Filing Analyses(6)
Armlogi Holding Corp.8-Knegativemateriality 9/10

20-04-2026

On April 17, 2026, Armlogi Holding Corp. received a Nasdaq notice for non-compliance with Listing Rule 5450(b)(1)(C), as its Market Value of Publicly Held Shares (MVPHS) fell below the $5,000,000 threshold for 30 consecutive business days. The Company has 180 calendar days until October 14, 2026, to regain compliance by maintaining MVPHS at or above $5,000,000 for 10 consecutive business days, with no immediate impact on trading under symbol BTOC. Failure to comply risks delisting or transfer to Nasdaq Capital Market, and the Company plans to monitor and address the issue but provides no assurance of success.

  • ·Trading symbol: BTOC on The Nasdaq Global Market
  • ·Nasdaq Listing Rule referenced: 5450(b)(1)(C) and 5810(c)(3)(D)
  • ·Company is an emerging growth company
  • ·Principal executive offices: 20301 East Walnut Drive North, Walnut, CA 91789
QVC Group, Inc.8-Knegativemateriality 10/10

20-04-2026

QVC Group, Inc. received a Nasdaq notice on April 17, 2026, determining delisting of its Series A common stock (QVCGA) and 8.0% Series A Cumulative Redeemable Preferred Stock (QVCGP) effective April 24, 2026, due to its Chapter 11 bankruptcy filing on April 16, 2026, public interest concerns, and doubts on continued listing compliance. Separately, its Series B common stock (QVCGB) is being downgraded from OTCQB Venture Market to OTCID Basic Market effective April 20, 2026. The company does not intend to appeal and warns that equity holders expect no recovery as interests will likely be cancelled under its prepackaged reorganization plan.

  • ·Nasdaq determination based on bankruptcy filing, public interest concerns, residual equity interest doubts, and compliance sustainability.
  • ·Company has right to appeal under Nasdaq Rule 5800 Series but does not intend to.
  • ·Delisting not expected to affect business operations or Chapter 11 Cases; anticipates OTC Markets trading post-suspension but with no assurances on volume or continuity.
  • ·Trading in securities highly speculative with prices unrelated to potential bankruptcy recovery.
QVC INC8-Knegativemateriality 10/10

20-04-2026

QVC, Inc. received notice on April 17, 2026, from NYSE Regulation to delist its 6.375% Senior Secured Notes due 2067 (QVCD) and 6.250% Senior Secured Notes due 2068 (QVCC) from the NYSE due to the company's recent Chapter 11 bankruptcy filing by QVC Group and affiliates, with trading suspended immediately. The company does not intend to appeal the delisting determination. While the delisting is not expected to affect business operations or the bankruptcy proceedings, trading in the company's securities is highly speculative, with the notes set to be cancelled under the prepackaged reorganization plan and equity interests receiving no distributions.

  • ·Trading in the Listed QVC Notes on the NYSE has been suspended immediately.
  • ·NYSE delisting determination pursuant to NYSE Listed Company Manual Section 802.01D.
  • ·Company has right to review by NYSE Board Committee but does not intend to appeal.
  • ·Holders of existing Listed QVC Notes will receive distributions under the Plan in satisfaction of claims, with no assurance of full recovery.
  • ·Holders of equity interests in QVC Group will receive no distributions and such interests will be cancelled for no consideration.
IT TECH PACKAGING, INC.8-Knegativemateriality 9/10

20-04-2026

IT Tech Packaging, Inc. received an NYSE American Notice of noncompliance on April 16, 2026, due to failure to file its Form 10-K for the year ended December 31, 2025, by the April 15, 2026 due date, triggered by inability to finalize financial results and disclosures without unreasonable effort. The notice initiates procedures under Section 1007 of the NYSE American Company Guide, providing an initial six-month cure period (with possible additional six months) to file the delinquent report, but no immediate effect on listing or trading; however, failure to cure risks suspension and delisting at NYSE's discretion. The company intends to file as soon as practicable within the cure period but provides no assurance of regaining compliance.

  • ·Company filed Notification of Late Filing on Form 12b-25 with SEC on March 31, 2026.
  • ·Common Stock, par value $0.001 per share, trading symbol ITP on NYSE American LLC.
  • ·Production facilities located in Baoding and Xingtai, Hebei Province, North China.
NOCERA, INC.8-Knegativemateriality 10/10

20-04-2026

On April 17, 2026, Nocera, Inc. received a notice from Nasdaq stating that the company fails to meet the minimum stockholders’ equity requirement of $2.5 million for continued listing on The Nasdaq Capital Market, as its Form 10-K for the year ended December 31, 2025, reports stockholders’ equity of $(440,735). The company has 45 days until June 1, 2026, to submit a compliance plan, with a possible extension of up to 180 calendar days if accepted. Trading of NCRA common stock continues unaffected, but there is no assurance Nasdaq will approve the plan or that compliance will be regained.

  • ·Common stock trades under symbol NCRA on The Nasdaq Capital Market with no immediate delisting effect.
  • ·Company is an emerging growth company.
  • ·Principal executive offices: 3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City Taiwan 221, ROC.
OneMedNet Corp8-Knegativemateriality 9/10

20-04-2026

On April 14, 2026, OneMedNet Corporation received a notice from Nasdaq's Listing Qualifications Department stating non-compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), based on the closing bid price for the last 30 consecutive business days. The company has 180 calendar days, until October 12, 2026, to regain compliance by achieving a bid price of at least $1.00 per share for 10 consecutive business days, with potential for an additional 180-day period if other listing standards are met. The company plans to monitor the situation and may implement a reverse stock split, but there is no assurance of regaining compliance, risking delisting.

  • ·Non-compliance based on closing bid price for 30 consecutive business days.
  • ·Nasdaq Listing Rule 5810(c)(3)(A) provides the initial 180-calendar-day grace period.
  • ·Eligibility for second 180-day period requires meeting market value of publicly held shares and other initial listing standards (except bid price), plus written notice of intent to cure via reverse stock split if necessary.

Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 6 filings

More from: US SEC Trading Suspension Halt Orders

🇺🇸 More from United States

View all →